期刊
BMC MEDICINE
卷 11, 期 -, 页码 -出版社
BIOMED CENTRAL LTD
DOI: 10.1186/1741-7015-11-166
关键词
Acute lung injury; Acute respiratory distress syndrome
资金
- Astrazenica
- MRC [G0701690, MC_G1002460] Funding Source: UKRI
- Medical Research Council [G0701690, MC_G1002460] Funding Source: researchfish
- Public Health Agency [EAT/3724/07, EAT/4210/09] Funding Source: researchfish
Despite its high incidence and devastating outcomes, acute respiratory distress syndrome ( ARDS) has no specific treatment, with effective therapy currently limited to minimizing potentially harmful ventilation and avoiding a positive fluid balance. Many pharmacological therapies have been investigated with limited success to date. In this review article we provide a state-of-the-art update on recent and ongoing trials, as well as reviewing promising future pharmacological therapies in ARDS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据